New Research on Osteosarcomas from Second Affiliated Hospital of Zhengzhou University Summarized ([223Ra] RaCl2 nanomicelles showed potent effect against osteosarcoma: targeted alpha therapy in the nanotechnology era)

Prensa/medios de comunicación: !!!Research

Períododic. 12 2022

Cobertura de los medios

1

Cobertura de los medios

  • NombreNew Research on Osteosarcomas from Second Affiliated Hospital of Zhengzhou University Summarized ([223Ra] RaCl2 nanomicelles showed potent effect against osteosarcoma: targeted alpha therapy in the nanotechnology era)
    Nombre/canal del medio de comunicaciónClinical Trials Daily
    País/TerritorioEstados Unidos
    Fecha12/12/22
    PersonasYang Yang
Ver todos 1
Ver menos